The investigators believe that disclosure of HIV status could influence medication adherence. If disclosure leads to social support, adherence could be improved. This study purpose is to assess correlation between disclosure and medication adherence, and to describe people whose HIV status has been disclosed to.
Pharmacists administer a questionnaire to each consecutive subject taking part in the adherence-enhancing program at the pharmacy of the Department of Ambulatory Care And Community Medicine in Lausanne. This questionnaire assesses disclosure, response to disclosure, and living situation. Adherence is measured by electronic monitoring and pill count.
Study Type
OBSERVATIONAL
Enrollment
120
Policlinique Médicale Universitaire
Lausanne, Canton of Vaud, Switzerland
Patient Adherence
Electronic monitoring of adherence during 30 days before survey
Time frame: 30 days before survey
Patient Adherence
Electronic monitoring of adherence during 90 days before survey
Time frame: 90 days before survey
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.